To Assess Cardiovascular Function

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Semler Scientific
Semler ScientificCA - Santa Clara
1 program
QuantaFlo HDN/A1 trial
Active Trials
NCT07219693RecruitingEst. Jun 2026

Trial Timeline

Clinical trial activity over time

2025
2026
Semler ScientificQuantaFlo HD

Clinical Trials (1)

NCT07219693Semler ScientificQuantaFlo HD

QuantaFlo HD Clinical Validation Study

Start: Aug 2025Est. completion: Jun 2026
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space